Epidemiologist stresses COVID-19 pathophysiologic research
chinadaily.com.cn |
Updated: 2020-03-19 08:00
Share
Share - WeChat
More research should be done on the overreaction of the immune response in COVID-19 disease, said Zhong Nanshan, China's leading epidemic control expert, in a recent video talk.
Zhong also noted that once the patients deteriorate, the survival rate is pretty low, as some of the pathophysiologic characteristics are different from usual cases of ARDS, or acute respiratory distress syndrome.
Zhong shared China's experience in the fight against the coronavirus with Dr. Anita Simonds, the president-elect of the European Respiratory Society, in an online conversation earlier this month.
- Global engineering congress to be held in Shanghai
- 'Lingka' custom in Xizang evolves into new form of cultural tourism, vibrant lifestyle
- From logging to guardianship: How China protects green source of its 'mother river'
- China rescues 10 Myanmar seafarers in South China Sea
- Qingdao sees surge in travelers to S Korea under its temporary visa-free policy
- China's 2025 box office surpasses 2024's full-year gross
